Incannex Healthcare Inc
NASDAQ:IXHL 4:00:00 PM EDT
| Market Cap (Intraday) | 19.57M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.21 |
| 50-Day MA | $0.25 |
| 200-Day MA | $1.29 |
Incannex Healthcare Inc Stock, NASDAQ:IXHL
8 Century Circuit, Suite 105, Norwest, New South Wales (NSW) 2153
Australia
Phone: +61.4.984.0786
Number of Employees: 9
Description
Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on July 5, 2023 and is headquartered in Norwest, Australia.